Approximately 80 percent of people who use heroin report that their opioid use began with prescription painkillers. The pipeline from prescription to illicit opioids is driven by a predictable sequence: legitimate pain treatment leads to physical dependence, tolerance requires higher doses, prescriptions are reduced or discontinued, and the person turns to cheaper, more accessible heroin or illicit fentanyl to avoid withdrawal. Understanding this pipeline is essential for prevention, early intervention, and reducing the stigma that prevents people from seeking help.
How It Starts: The Prescription
“Almost nobody wakes up one morning and decides to try heroin,” says Dr. Ponlawat Pitsuwan, Physician at Phuket Island Rehab. “The vast majority of the heroin patients I treat started with a prescription after surgery, an injury, or a dental procedure. They took the medication exactly as prescribed, developed tolerance, and found themselves in a situation where the medical system that created their dependence was unable or unwilling to manage it.”
Prescription opioids, including oxycodone (OxyContin, Percocet), hydrocodone (Vicodin), morphine, and codeine, are effective analgesics for acute pain. For short-term use lasting days to weeks, the risk of developing addiction is relatively low. The problem emerges with longer prescriptions. Physical dependence, where the body adapts to the opioid and produces withdrawal symptoms upon cessation, develops within two to four weeks of daily use. Tolerance, where the same dose produces less pain relief, typically develops on a similar timeline.
These are normal pharmacological responses, not signs of moral weakness. The same mu-opioid receptor mechanisms that make these medications effective for pain also make them dependence-producing with sustained use. The medical system’s failure was not in prescribing opioids for genuine pain but in prescribing them for longer durations than the evidence supported, in failing to monitor for signs of dependence, and in having no adequate plan for the patients who became dependent under medical supervision.
The Transition Point: When Prescriptions End
The critical transition occurs when the prescription is reduced, discontinued, or becomes unaffordable. The patient is now physically dependent, meaning that stopping the medication produces withdrawal symptoms: muscle aches, nausea, diarrhoea, anxiety, insomnia, and intense cravings. For many patients, the prescribing physician either tapers the medication faster than the body can adjust or discontinues it abruptly, sometimes due to regulatory pressure, practice guidelines, or concern about legal liability.
The patient is left with two options: endure withdrawal or find another source of opioids. Many initially turn to prescription opioid diversion, obtaining pills through friends, family, or the black market. But diverted prescription opioids are expensive, often costing 30 to 80 USD per pill on the street. Heroin, which activates the same receptors and relieves the same withdrawal, costs a fraction of the price. Illicit fentanyl, now the dominant product in many heroin markets, is cheaper still.
The economic logic is brutally simple: a person spending 200 to 400 USD per day on diverted pills can achieve the same effect for 20 to 50 USD per day with heroin. For someone in the grip of withdrawal, with their body screaming for relief, the rational calculation overwhelms the stigma barrier.
| Stage | What Happens | Neurological Driver | Typical Timeline |
|---|---|---|---|
| Legitimate prescription | Pain relief from surgery, injury, or chronic condition | Mu-opioid receptor activation, pain suppression | Days to weeks |
| Physical dependence | Body adapts; missing a dose produces discomfort | Receptor downregulation, norepinephrine upregulation | 2 to 4 weeks of daily use |
| Tolerance and dose escalation | Same dose no longer works; requests for higher doses | D2 receptor downregulation, reduced opioid sensitivity | 4 to 12 weeks |
| Prescription reduced or ended | Withdrawal symptoms emerge; patient seeks alternatives | Acute norepinephrine surge, dopamine deficit | Variable |
| Diversion or illicit use | Buying pills, then transitioning to heroin or fentanyl | Same receptor, lower cost, higher availability | Weeks to months after prescription ends |
The Numbers Behind the Pipeline
The data confirming this pipeline is extensive. A landmark SAMHSA survey found that 80 percent of heroin users reported that their first opioid was a prescription painkiller. The National Institute on Drug Abuse (NIDA) estimates that approximately 4 to 6 percent of people who misuse prescription opioids transition to heroin. While this percentage may seem small, applied to the millions of people prescribed opioids over the past two decades, it represents hundreds of thousands of transitions.
The pipeline has evolved over time. In the early 2000s, the primary product at the end of the pipeline was heroin. Since approximately 2014, illicitly manufactured fentanyl has increasingly replaced heroin in the supply chain. Many people who believe they are buying heroin are now receiving fentanyl or a fentanyl-heroin mixture, often without their knowledge. This substitution has made the endpoint of the prescription pipeline dramatically more lethal: fentanyl overdose kills faster and requires more naloxone to reverse.
Who Is Most Vulnerable
Not everyone who receives a prescription opioid progresses through the pipeline. Risk factors that increase vulnerability include longer duration of initial prescription (particularly beyond 90 days), higher doses prescribed (particularly above 90 morphine milligram equivalents per day), history of substance use disorder (including alcohol use disorder), co-occurring mental health conditions (particularly depression and anxiety), younger age at first prescription, and genetic variations affecting opioid metabolism and reward sensitivity.
Socioeconomic factors also play a role. Limited access to pain management alternatives (physical therapy, non-opioid medications, interventional procedures), inadequate health insurance that does not cover addiction treatment, geographic isolation from treatment facilities, and stigma that prevents help-seeking all increase the likelihood that dependence progresses to illicit use.
Breaking the Pipeline: What Works
Prevention begins at the prescribing stage. Evidence-based prescribing guidelines now recommend limiting initial opioid prescriptions for acute pain to three to seven days, using the lowest effective dose, and avoiding long-acting formulations for acute pain. Prescription drug monitoring programmes (PDMPs), which track controlled substance prescriptions across pharmacies and prescribers, help identify patterns of escalating use early.
When dependence has developed, the most effective intervention is medication-assisted treatment (MAT) rather than abrupt discontinuation. Buprenorphine (Suboxone) and methadone are evidence-based medications that relieve withdrawal and cravings without producing the euphoria of full opioid agonists. Starting MAT before or immediately after prescription discontinuation prevents the withdrawal crisis that drives the transition to heroin. Research consistently shows that MAT reduces illicit opioid use by 60 to 80 percent and reduces overdose death by more than 50 percent.
Treatment for people who have already transitioned to heroin or fentanyl follows the same principles but requires additional clinical attention to the more complex pharmacology of illicit opioids, the increased overdose risk, and the social consequences that accumulate as the addiction progresses. Residential treatment at Phuket Island Rehab provides medically managed withdrawal, MAT initiation, intensive psychotherapy, and comprehensive aftercare planning within a setting that removes the person from the environment associated with their use.
When Opioid Use Has Become More Than Medical
The transition from medical use to addiction is often invisible to the person experiencing it. Warning signs include taking more than prescribed, running out early, visiting multiple doctors for prescriptions, using the medication for its mood effects rather than for pain, continuing to seek opioids after the pain condition has resolved, and experiencing withdrawal symptoms between doses. If you recognise these signs in yourself or someone you care about, the earlier intervention occurs, the better the outcome. The pipeline does not have to reach its endpoint.
Summary
The prescription-to-heroin pipeline is a well-documented phenomenon driven by the pharmacology of opioid dependence, the economics of the illicit drug market, and systemic failures in how the medical system has managed chronic pain. Approximately 80 percent of heroin users began with prescription painkillers. The pipeline can be interrupted through evidence-based prescribing, medication-assisted treatment for those who develop dependence, and comprehensive addiction treatment for those who have progressed to illicit use.
“Nobody in this pipeline made a single catastrophic decision,” says Dr. Ponlawat Pitsuwan. “They made a series of understandable decisions, each one driven by the body’s need to avoid withdrawal and the brain’s need for the substance it had been taught to depend on. Understanding this sequence removes the stigma and replaces it with something more useful: a clear treatment path at every stage.”
Frequently Asked Questions
Does everyone who takes prescription painkillers become addicted?
No. The majority of people who receive short-term opioid prescriptions for acute pain do not develop addiction. Risk increases significantly with prescriptions lasting beyond 90 days, higher doses, and the presence of risk factors such as a personal or family history of substance use disorder, co-occurring mental health conditions, or younger age. Short-term prescriptions of three to seven days for acute pain carry relatively low risk.
Why is heroin cheaper than prescription opioids?
Prescription opioids are manufactured under pharmaceutical regulations, sold through licensed pharmacies, and priced to cover research, development, marketing, and regulatory compliance. Heroin and illicit fentanyl are produced without these costs, often in clandestine laboratories with cheap precursor chemicals. A single dose of diverted oxycodone may cost 30 to 80 USD on the street, while a comparable dose of heroin costs 5 to 15 USD, and illicit fentanyl is cheaper still.
Can someone go from prescription painkillers directly to fentanyl without using heroin first?
Yes, and this is increasingly common. As fentanyl has replaced heroin in many drug markets, people transitioning from prescription opioids may encounter fentanyl as their first illicit opioid, often in the form of counterfeit prescription pills (fake oxycodone or hydrocodone tablets that actually contain fentanyl). This direct prescription-to-fentanyl transition is particularly dangerous because the person may not know they are taking fentanyl and has no basis for gauging the dose.
What should I do if my doctor suddenly reduces my opioid prescription?
Do not supplement with opioids from other sources. Discuss your concerns with your prescribing doctor or seek a second medical opinion. Ask about non-opioid pain management alternatives and about medication-assisted treatment if you are experiencing dependence. If your doctor is unwilling to manage a safe taper or transition, seek care from an addiction medicine specialist or pain management clinic that can provide appropriate supervision.
Is medication-assisted treatment just substituting one addiction for another?
No. This is one of the most harmful misconceptions about MAT. Buprenorphine and methadone activate opioid receptors at levels that prevent withdrawal and reduce cravings without producing the euphoria, impairment, and escalation cycle of addiction. They stabilise brain chemistry, allowing the person to function normally, work, maintain relationships, and engage in therapy. Research consistently shows that MAT improves every measurable outcome compared to abstinence-only approaches: reduced illicit use, reduced overdose death, improved employment, improved retention in treatment.
How can families help prevent the transition from pills to heroin?
Safe storage and disposal of prescription opioids reduces access. Monitoring for signs of escalating use (running out early, seeking additional prescriptions, behavioural changes) enables early intervention. Having an open, non-judgemental conversation about the risks of prescription opioid dependence before it develops is more effective than waiting for a crisis. If dependence has already developed, encouraging professional treatment and supporting MAT as a valid medical approach rather than stigmatising it as “more drugs” can prevent the transition to illicit use.
Sources:
Muhuri, P. K., Gfroerer, J. C., & Davies, M. C. (2013). Associations of nonmedical pain reliever use and initiation of heroin use in the United States. CBHSQ Data Review, SAMHSA.
National Institute on Drug Abuse (2024). Prescription Opioids and Heroin Research Report. NIDA.
Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016). Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine, 374(2), 154-163.
Substance Abuse and Mental Health Services Administration (2020). TIP 63: Medications for Opioid Use Disorder. SAMHSA.
Prescription opioids, oxycodone, hydrocodone, morphine, codeine, heroin, fentanyl, mu-opioid receptor, tolerance, physical dependence, withdrawal, prescription drug monitoring programme, PDMP, medication-assisted treatment, MAT, buprenorphine, Suboxone, methadone, naltrexone, SAMHSA, NIDA, opioid epidemic, counterfeit pills, diversion, Phuket Island Rehab